B-intervention	0	9	Cognitive
I-intervention	10	20	Behavioral
I-intervention	21	27	Stress
I-intervention	28	38	Management
O	39	42	for
B-eligibility	43	50	Healthy
I-eligibility	51	56	Women
I-eligibility	57	59	at
I-eligibility	60	64	Risk
I-eligibility	65	68	for
I-eligibility	69	75	Breast
I-eligibility	76	82	Cancer
O	82	83	:
O	84	85	a
O	86	91	Novel
O	92	103	Application
O	104	106	of
O	107	108	a
O	109	115	Proven
O	116	128	Intervention
O	128	129	.

O	130	135	Women
O	136	138	at
O	139	143	risk
O	144	147	for
O	148	154	breast
O	155	161	cancer
O	162	168	report
O	169	177	elevated
O	178	191	psychological
O	192	200	distress
O	200	201	,
O	202	207	which
O	208	211	has
O	212	216	been
O	217	226	adversely
O	227	237	associated
O	238	242	with
O	243	249	cancer
O	249	250	-
O	250	258	relevant
O	259	268	behaviors
O	269	272	and
O	273	280	biology
O	280	281	.

O	282	285	The
O	286	293	present
O	294	299	study
O	300	306	sought
O	307	309	to
O	310	317	examine
O	318	321	the
O	322	329	effects
O	330	332	of
O	333	334	a
O	335	337	10
O	337	338	-
O	338	342	week
O	343	352	cognitive
O	353	363	behavioral
O	364	370	stress
O	371	381	management
O	382	383	(
O	383	387	CBSM
O	387	388	)
O	389	394	group
O	395	407	intervention
O	408	410	on
O	411	419	distress
O	420	425	among
O	426	431	women
O	432	436	with
O	437	438	a
O	439	445	family
O	446	453	history
O	454	456	of
O	457	463	breast
O	464	470	cancer
O	470	471	.

O	472	484	Participants
O	485	489	were
O	490	498	randomly
O	499	507	assigned
O	508	510	to
O	511	515	CBSM
O	516	517	(
O	517	518	N
O	519	520	=
B-intervention-participants	521	523	82
O	523	524	)
O	525	527	or
O	528	529	a
B-control	530	534	wait
I-control	534	535	-
I-control	535	539	list
I-control	540	550	comparison
I-control	551	556	group
O	557	558	(
O	558	559	N
O	560	561	=
B-control-participants	562	564	76
O	564	565	)
O	565	566	.

O	567	575	Baseline
O	576	578	to
O	579	595	postintervention
O	596	603	effects
O	604	606	of
O	607	611	CBSM
O	612	614	on
O	615	625	depressive
O	626	634	symptoms
O	635	638	and
O	639	648	perceived
O	649	655	stress
O	656	660	were
O	661	669	examined
O	670	675	using
O	676	688	hierarchical
O	689	699	regression
O	699	700	.

O	701	705	CBSM
O	706	718	participants
O	719	727	reported
O	728	741	significantly
O	742	747	lower
B-outcome	748	761	posttreatment
I-outcome	762	772	depressive
I-outcome	773	781	symptoms
O	782	783	(
O	783	784	β
O	785	786	=
O	787	788	-
O	788	789	0
O	789	790	.
O	790	792	17
O	792	793	,
O	794	795	p
O	796	797	<
O	798	799	0
O	799	800	.
O	800	802	05
O	802	803	)
O	804	807	and
B-outcome	808	817	perceived
I-outcome	818	824	stress
O	825	826	(
O	826	827	β
O	828	829	=
O	830	831	-
O	831	832	0
O	832	833	.
O	833	835	23
O	835	836	,
O	837	838	p
O	839	840	<
O	841	842	0
O	842	843	.
O	843	845	05
O	845	846	)
O	847	851	than
O	852	856	wait
O	856	857	-
O	857	861	list
O	862	872	comparison
O	873	885	participants
O	885	886	.

O	887	899	Additionally
O	899	900	,
O	901	908	greater
O	909	919	relaxation
O	920	928	practice
O	929	938	predicted
O	939	944	lower
B-outcome	945	953	distress
O	953	954	.

O	955	960	Group
O	960	961	-
O	961	966	based
O	967	971	CBSM
O	972	984	intervention
O	985	987	is
O	988	996	feasible
O	997	1000	and
O	1001	1004	can
O	1005	1011	reduce
O	1012	1025	psychological
O	1026	1034	distress
O	1035	1040	among
O	1041	1046	women
O	1047	1051	with
O	1052	1053	a
O	1054	1060	family
O	1061	1068	history
O	1069	1071	of
O	1072	1078	breast
O	1079	1085	cancer
O	1085	1086	.

O	1087	1090	The
O	1091	1098	present
O	1099	1107	findings
O	1108	1117	represent
O	1118	1120	an
O	1121	1132	encouraging
O	1133	1139	avenue
O	1140	1143	for
O	1144	1147	the
O	1148	1154	future
O	1155	1166	application
O	1167	1169	of
O	1170	1174	CBSM
O	1174	1175	.

O	1176	1177	(
O	1178	1192	Clinicaltrials
O	1192	1193	.
O	1193	1196	gov
O	1197	1203	number
O	1204	1215	NCT00121160
O	1215	1216	)
O	1216	1217	.
